The therapy also drove additional weight loss at the higher 1.8 mg dose without plateauing and maintained a favorable tolerability profile
The initiative is focused on a problem that continues to plague cancer outcomes in India
The seminar aimed to raise public awareness about inflammageing—chronic, low-grade inflammation that silently damages the body and accelerates ageing
The study is being conducted under a USFDA IND, has received U.S. Fast Track Designation for SLE-ITP, and has obtained IND approval from China’s Center for Drug Evaluation
Company acquires People Tree Hospital Yeshwanthpur for Rs. 430 crore
The approval for Exdensur (depemokimab-ulaa) comes on the back of SWIFT-1 and SWIFT-2 Phase III trials
The company operates a chain of mid-sized multi-speciality hospitals
Convenient subcutaneous option has potential to reach more patients with same clinical benefits as Saphnelo IV infusion
Qfitlia is the first antithrombin (AT)-lowering therapy approved for routine prophylaxis in hemophilia
WINREVAIR is currently the first and only activin signalling inhibitor approved for PAH across all 27 EU member states
Subscribe To Our Newsletter & Stay Updated
